Investors & Media International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial Lifeline Skin Care a Subsidiary of ISCO Announces New Products and Marketing Campaigns International Stem Cell Corporation Announces Second Patient with Parkinson's Disease Treated in Phase I Clinical Trial International Stem Cell Corporation Announces Operating Results for the Three and Nine-months ended September 30, 2016 International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson's Disease at the Neuroscience 2016 Conference International Stem Cell Corporation Announces Positive Efficacy Results in Traumatic Brain Injury International Stem Cell Corporation Publishes Results of Safety Studies Conducted in Support of the First Human Pluripotent Stem Cell Based Therapy for Parkinson's Disease International Stem Cell Corporation to Present at the 18th Annual Rodman and Renshaw Global Investment Conference International Stem Cell Corporation Announces Operating Results for the Three and Six-Months Ended June 30, 2016 International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC 1 2 3 4 5 6 7 8 9 10 11 << < > >>
